- $5.41bn
- $7.67bn
- $7.54bn
- 83
- 87
- 64
- 92
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 5,271 | 5,043 | 6,955 | 10,015 | 7,536 |
Cost of Revenue | |||||
Gross Profit | 1,817 | 1,490 | 2,611 | 5,032 | 2,671 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 4,515 | 4,841 | 5,745 | 6,499 | 6,395 |
Operating Profit | 756 | 202 | 1,210 | 3,516 | 1,141 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 628 | 49 | 1,092 | 3,404 | 974 |
Provision for Income Taxes | |||||
Net Income After Taxes | 481 | 24 | 832 | 2,219 | 687 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 475 | 11 | 783 | 2,159 | 647 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 475 | 11 | 783 | 2,159 | 647 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.362 | 0.043 | 0.602 | 1.68 | 0.501 |
Dividends per Share |